DK0941110T3 - Anvendelse af keratinocyt vækstfaktor-2 - Google Patents

Anvendelse af keratinocyt vækstfaktor-2

Info

Publication number: DK0941110T3
Authority: DK; Denmark
Prior art keywords: growth factor; keratinocyte growth; kgf; pancreas; gums
Prior art date: 1996-10-15

Application number

DK97913676T

Other languages

English (en)

Inventor

David L Lacey

Thomas R Ulich

Dimitry M Danilenko

Catherine L Farrell

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-15

Filing date

1997-10-15

Publication date

2004-06-01

1997-10-15 Application filed by Amgen Inc filed Critical Amgen Inc

2004-06-01 Application granted granted Critical

2004-06-01 Publication of DK0941110T3 publication Critical patent/DK0941110T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)

DK97913676T 1996-10-15 1997-10-15 Anvendelse af keratinocyt vækstfaktor-2 DK0941110T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US2849596P	1996-10-15	1996-10-15
US3225396P	1996-12-06	1996-12-06
US3345796P	1996-12-10	1996-12-10

Publications (1)

Publication Number	Publication Date
DK0941110T3 true DK0941110T3 (da)	2004-06-01

Family

ID=27363283

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97913676T DK0941110T3 (da)	1996-10-15	1997-10-15	Anvendelse af keratinocyt vækstfaktor-2

Country Status (10)

Country	Link
EP (1)	EP0941110B1 (da)
JP (1)	JP4270580B2 (da)
AT (1)	ATE259651T1 (da)
AU (1)	AU725509B2 (da)
CA (1)	CA2268741C (da)
DE (2)	DE69727691T2 (da)
DK (1)	DK0941110T3 (da)
ES (2)	ES2216134T3 (da)
PT (1)	PT941110E (da)
WO (1)	WO1998016243A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
CA2316015A1 (en)	1997-12-22	1999-07-01	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
US6242666B1 (en) *	1998-12-16	2001-06-05	The Scripps Research Institute	Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
CA2375829A1 (en) *	1999-06-02	2000-12-07	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
EP1196441A1 (en) *	1999-07-02	2002-04-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
WO2001072957A2 (en) *	2000-03-31	2001-10-04	Nobuyuki Itoh	Fibroblast growth factor-like molecules and uses thereof
US7202066B2 (en) *	2002-01-29	2007-04-10	Carrington Laboratories, Inc.	Combination of a growth factor and a protease enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1064710C (zh) *	1993-03-26	2001-04-18	安姆根有限公司	角质细胞生长因子的治疗应用
WO1996025422A1 (en) *	1995-02-14	1996-08-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
JPH11513405A (ja) *	1995-10-11	1999-11-16	カイロンコーポレイション	創傷治癒のためのｐｄｇｆ、ｋｇｆ、ｉｇｆ、およびｉｇｆｂｐの配合物
WO1997013851A1 (en) *	1995-10-13	1997-04-17	Purdue Research Foundation	Improvement of fruit quality by inhibiting production of lipoxygenase in fruits

1997
- 1997-10-15 ES ES97913676T patent/ES2216134T3/es not_active Expired - Lifetime
- 1997-10-15 ES ES04003545T patent/ES2297286T3/es not_active Expired - Lifetime
- 1997-10-15 DE DE69727691T patent/DE69727691T2/de not_active Expired - Lifetime
- 1997-10-15 AT AT97913676T patent/ATE259651T1/de active
- 1997-10-15 AU AU50806/98A patent/AU725509B2/en not_active Ceased
- 1997-10-15 DK DK97913676T patent/DK0941110T3/da active
- 1997-10-15 PT PT97913676T patent/PT941110E/pt unknown
- 1997-10-15 EP EP97913676A patent/EP0941110B1/en not_active Expired - Lifetime
- 1997-10-15 WO PCT/US1997/018667 patent/WO1998016243A1/en active IP Right Grant
- 1997-10-15 DE DE69738336T patent/DE69738336T2/de not_active Expired - Lifetime
- 1997-10-15 JP JP51858998A patent/JP4270580B2/ja not_active Expired - Fee Related
- 1997-10-15 CA CA002268741A patent/CA2268741C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1998016243A1 (en)	1998-04-23
JP2001506586A (ja)	2001-05-22
AU725509B2 (en)	2000-10-12
ATE259651T1 (de)	2004-03-15
DE69738336D1 (de)	2008-01-10
EP0941110A1 (en)	1999-09-15
ES2297286T3 (es)	2008-05-01
DE69727691T2 (de)	2004-07-22
CA2268741C (en)	2007-04-24
CA2268741A1 (en)	1998-04-23
DE69727691D1 (de)	2004-03-25
JP4270580B2 (ja)	2009-06-03
EP0941110B1 (en)	2004-02-18
PT941110E (pt)	2004-07-30
AU5080698A (en)	1998-05-11
DE69738336T2 (de)	2008-04-03
ES2216134T3 (es)	2004-10-16

Similar Documents

Publication	Publication Date	Title
Aimetti et al.	2001	Maxillary sinus elevation: the effect of macrolacerations and microlacerations of the sinus membrane as determined by endoscopy.
NO953781L (no)	1995-11-27	Terapeutisk anvendelse av keratinocyttvekstfaktor
FR2721198B1 (fr)	1996-10-31	Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
TR200201440T2 (tr)	2002-08-21	Biomedikal kullanım için radyum-223 hazırlanması
WO2005097219A3 (en)	2005-12-22	Ecm-based graft material
BR0210056A (pt)	2006-04-04	composições e métodos para tratamento de hiperplasia
DK1131096T3 (da)	2010-05-17	Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer
DE69927176D1 (de)	2005-10-13	Zusammensetzungssammlung und kit für intraokuläre chirurgie
WO2004087006A3 (en)	2004-11-25	Implant delivery technologies
DK0637933T3 (da)	2005-02-28	Fremgangsmåde til behandling af organer og væv
AU5056196A (en)	1996-10-31	Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
BR0111300A (pt)	2003-06-10	Implante de neurotoxina
JPS6222617B2 (da)	1987-05-19
BR0212898A (pt)	2004-10-13	Método de tratamento de infecções do ouvido médio
DK0941110T3 (da)	2004-06-01	Anvendelse af keratinocyt vækstfaktor-2
DK1007566T3 (da)	2007-01-02	Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK0856312T3 (da)	1999-06-23	Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
CA2218333A1 (en)	1996-10-24	Surgical method for rejuvenating or reshaping body members by bone grafting _______________________________________________________
DK0821969T3 (da)	2007-03-26	Medicinsk sammensætning omfattende TCF-II
Shields et al.	1993	Hydroxyapatite orbital implant after enucleation for intraocular tumors
Hanna	2022	Complex and redo hypospadias repairs: management of 402 patients
RU2085163C1 (ru)	1997-07-27	Способ хирургической реконструкции наружного слухового прохода при его рубцовых стриктурах и облитерациях
RU97114014A (ru)	1999-07-20	Способ предупреждения послеоперационных осложнений при имплантации искусственного хрусталика
RU2001104568A (ru)	2002-11-27	Способ ампутации конечности при облитерирующих заболеваниях артерий